Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
Recent trials of intensive glycemic control suggest a possible link between hypoglycemia and excess cardiovascular mortality in patients with type 2 diabetes. Hypoglycemia might cause arrhythmias through effects on cardiac repolarization and changes in cardiac autonomic activity. Our aim was to study the risk of arrhythmias during spontaneous hypoglycemia in type 2 diabetic patients with cardiovascular risk. Twenty-five insulin-treated patients with type 2 diabetes and a history of cardiovascular disease or two or more risk factors underwent simultaneous continuous interstitial glucose and ambulatory electrocardiogram monitoring. Frequency of arrhythmias, heart rate variability, and markers of cardiac repolarization were compared between hypoglycemia and euglycemia and between hyperglycemia and euglycemia matched for time of day. There were 134 h of recording at hypoglycemia, 65 h at hyperglycemia, and 1,258 h at euglycemia. Bradycardia and atrial and ventricular ectopic counts were significantly higher during nocturnal hypoglycemia compared with euglycemia. Arrhythmias were more frequent during nocturnal versus daytime hypoglycemia. Excessive compensatory vagal activation after the counterregulatory phase may account for bradycardia and associated arrhythmias. QT intervals, corrected for heart rate, >500 ms and abnormal T-wave morphology were observed during hypoglycemia in some participants. Hypoglycemia, frequently asymptomatic and prolonged, may increase the risk of arrhythmias in patients with type 2 diabetes and high cardiovascular risk. This is a plausible mechanism that could contribute to increased cardiovascular mortality during intensive glycemic therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational reports in individuals with diabetes undergoing continuous glucose and electrocardiogram (ECG) monitoring have noted an increased prevalence of arrhythmias during periods of hypoglycemia as compared to euglycemia (5, 6).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [5]
In the citing paper
“They can also be vulnerable to irregular heartbeat, which can be life-threatening45.”
From A wearable patch for continuous analysis of thermoregulatory sweat at rest (2021) · cites this paper as [45]
In the citing paper
“In contrast, patients with diabetes may have a lower risk of inappropriate therapy or ICD shock, since they may be more sedentary with consequently less frequent exercise-induced sinus tachycardia and also lower incidence of lead fracture.600,658,659”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [658]
In the citing paper
“Observational studies have reported significant corrected QT (QTc) interval prolongation possibly associated with microvascular complications, atypical patterns of microvolt T-wave alternans, altered heart rate variability, or heart rate turbulence in patients with diabetes, but none of these tests should routinely be used to stratify the risk of ventricular arrhythmias or SCD in clinical practice”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [658]
Citations
Cites
Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use
Electrophysiology, T. F. O. T. E. S. O. C. T. N. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.1043 · Cited by 17,159
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., & Schwartz, P. J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014868 · Cited by 15,289
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“Intensive glycemic control for between 3 and 5 years did not reduce cardiovascular mortality in recent trials (2,3) and the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was terminated early owing to increased mortality in patients with type 2 diabetes at high cardiovascular risk (4).”
BackgroundTesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Cardiac Electrophysiology: From Cell to Bedside
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-12-1069_5 · Cited by 2,385
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Self-citationDiagnosis and management of diabetic autonomic neuropathy.
Ewing, D. J., & Clarke, B. F. (1982) · BMJ · doi:10.1136/bmj.285.6346.916 · Cited by 1,235
Montano, N., Ruscone, T. G., Porta, A., Lombardi, F., Pagani, M., & Malliani, A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1826 · Cited by 1,108
Cited by
Items 301–400 of 402
Sedova, K. A., Vaykshnorayte, M. A., Ovechkin, A. O., Kneppo, P., Bernikova, O. G., Vityazev, V. A., & Azarov, J. E. (2016) · Physiological Research · doi:10.33549/physiolres.933161 · Cited by 2
Junttila, I., Vuorio, A. F., Budowle, B., Laukkala, T., & Sajantila, A. (2018) · International Journal of Legal Medicine · doi:10.1007/s00414-018-1879-4 · Cited by 2
Junctional rhythm during hypoglycaemic encephalopathy
Saleh, A. S. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0795-z · Cited by 2
Predicting risk of severe hypoglycaemia in type 2 diabetes
Neupane, S., & Evans, M. L. (2015) · Diabetologia · doi:10.1007/s00125-015-3550-7 · Cited by 2
Kern, W. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0100-y · Cited by 2
“Kontinuierliche Glukosemessungen zeigten, dass Blutzuckerwerte 60 mg/dl innerhalb von 3 Tagen bei 62,5 % der Menschen mit T1DM (Diabetes mellitus Typ 1) und bei 46,6 % der insulinbehandelten Menschen mit T2DM auftreten, ohne dass sie subjektiv bemerkt wurden [4].”
BackgroundInfluentialBEST METHOD TO PREVENT COMPLICATIONS OF DIABETES MELLITUS IS TO ACHIEVE TARGET GLYCAEMIA VALUES
Mkrtumyan, A. M., & Solovieva, I. V. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-12-170-174 · Cited by 2
ÇALIŞKAN, S. G., Hacıağaoğlu, N., Tüzün, S., Öner, C., Şimşek, E. E., & Çetin, H. (2022) · Turkish Journal of Family Medicine & Primary Care · doi:10.21763/tjfmpc.1023039 · Cited by 3
Lee, S., Liu, T., Chung, C. T., Reinhold, J., Vassiliou, V. S., & Tse, G. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00012-7 · Cited by 3
“It was found that persistent hypoglycemia, albeit asymptomatic, may be pro-arrhythmic for patients with T2DM and high cardiovascular risks 20 .”
L’internista ospedaliero nella gestione del paziente diabetico complesso
Magnani, G. E. L., Beltramello, G., Brancato, D., Fontanella, A., & Nardi, R. (2018) · Italian Journal of Medicine · doi:10.4081/itjm.q.2018.2 · Cited by 2
Temporal Relationship of Glycemia With Cardiac Arrhythmias in Patients With Type 2 Diabetes and CKD
Bansal, N., Zelnick, L. R., Hirsch, I. B., Trence, D., AKOUM, N. W., & de Boer, I. H. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.08.008 · Cited by 3
Lyhne, M. K., Vegge, A., Povlsen, G. K., Slaaby, R., Kildegaard, J., Pedersen‐Bjergaard, U., & Olsen, L. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-84758-w · Cited by 2
Risk Stratification According to Insulin Type: Reply
Cosmi, F., Staszewsky, L. I., McMurray, J. J. V., & Latini, R. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1218 · Cited by 2
Tse, G., Lee, T. T. L., Hui, J. M. H., Lee, Y. H. A., Satti, D. I., Shum, Y. K. L., Tang, P., Wai, A. K. C., Liu, T., Wong, W. T., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1309807/v1 · Cited by 2
You, Q.-Y., Xu, B., & Zhuge, F. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01151-7 · Cited by 1
Ando, T., Kondo, M., Asada‐Yamada, Y., Kawai, M., Asano‐Hayami, E., Hayami, T., Motegi, M., Ejima, Y., Nagao, E., Kasagi, R., et al. (2023) · Diabetology International · doi:10.1007/s13340-023-00651-z · Cited by 1
Sanke, T., Matsuoka, Y., Kadoya, Y., Yamada, S., Tamagawa, E., & Fujita, A. (2025) · Diabetology · doi:10.3390/diabetology6110138 · Cited by 1
Bruns, F., Fender, A. C., Poppenborg, T., Dudley, S. C., & Dobrev, D. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf252 · Cited by 2
Liu, Y., Guo, C., Li, X., Li, S., Huang, J., Zhao, L., Zhu, Y., Liu, X., Wang, B., Lin, R., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1685969 · Cited by 2
“NH can impact multiple organs including the heart, nervous system, and kidneys (7 – 10); and in severe cases, may lead to bradyarrhythmias, cardiac arrest, and even death (7, 11, 12).”
Chang, S., Peng, Y., Luo, M., Lv, D., Li, N., Zhang, G., Jiang, Y., Ma, D., Huang, Y., Li, X., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07935-3 · Cited by 1
“While some studies have explored cardiac electrophysiological explanations, the underlying mechanisms of hypoglycemia-induced adverse cardiac outcomes remain unclear [3, 4].”
Hayashi, A., TAKAESU, R., Sogabe, H., Tani, Y., Aoki, N., Ko, Y., Tsuji, S., Moriguchi, I., Kobayashi, N., & Miyatsuka, T. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02261-7 · Cited by 1
“Hypoglycemia was defined as SGL readings below 70 mg/dL for a duration exceeding 15 min [19, 20].”
Pal, A. W., Chong, W. L., Huri, H. Z., & Ratnasingam, J. (2026) · Diabetic Medicine · doi:10.1111/dme.70360 · Cited by 1
“For individuals with a recent myocardial infarction, standard HbA1c often fails to capture the acute hypoglycaemic events that trigger pro-arrhythmic variability, 67 suggesting the benefit of CGM lies in its predictive alerts rather than overall glucose lowering.”
Hypoglycemia, insulin resistance, and cardiovascular disease: A possible link
Iqbal, A., Chaudhury, T., & Heller, S. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00028-1 · Cited by 1
Self-citationHypoglycemia, Arrythmia and Mortality in Diabetes, an underestimated risk?
Kasperek, B., Tymoszuk, P., Augustowska, K., Żak-Gontarz, A., Sierzpowski, R., Protasiuk, A., Loryś, L., Klimczak, K., & Budzyńska, K. (2025) · Quality in Sport · doi:10.12775/qs.2025.42.61151 · Cited by 1
Future of once-weekly insulins in type 2 diabetes: efficacy and safety
Chow, E. W.-K., & Chow, E. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01098-0 · Cited by 1
Self-citationSinghal, M., McAdam-Marx, C., Lafleur, J., Witt, D., Nelson, R., & Biskupiak, J. E. (2016) · Value in Health · doi:10.1016/j.jval.2016.03.254 · Cited by 1
Quelle place pour les nouveaux antidiabétiques dans la prise en charge du diabète du sujet âgé ?
Blickle, J. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30172-9 · Cited by 1
Cryer, P. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00034-4 · Cited by 5
Inobvious complications of hypoglycaemia
Majkowska, L. (2017) · Clinical Diabetology · doi:10.5603/dk.2017.0025 · Cited by 1
Zhuravlyova, L., Sokolnikova, N. V., & Rogachova, T. (2021) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2021.02.022 · Cited by 1
Atrial fibrillation in diabetic patients.
Serik, S. A., & Strona, V. I. (2021) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2021.02.103 · Cited by 1
Long-Term, Single-Centre Observation of Patients with Cardiac Implantable Electronic Devices
Załuska, R., Milewska, A. J., Moumtzoglou, A. S., Grabowski, M., & Drygas, W. (2021) · Medicina · doi:10.3390/medicina57121357 · Cited by 1
“The risk of bradyarrhythmia increases during states of hypoglycaemia [24].”
BackgroundConsoli, A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_21 · Cited by 1
Effects of intensive glycaemic control on ischaemic heart disease
Tsujimoto, T., & Yamamoto‐Honda, R. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60632-8 · Cited by 1
Potter, P. G. W., Walker, J. M. V., Robb, J. L., Chilton, J. K., Williamson, R., Randall, A. D., Ellacott, K. L. J., & Beall, C. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/271981 · Cited by 1
“For patients, it is a major barrier to enjoying the health benefits of exercise [1, 2] and is increasingly thought to contribute directly to an increased risk of cardiovascular events in type 1 and type 2 diabetes [3, 4].”
BackgroundComment on: Reversal of Roux-en-Y gastric bypass: largest single-institution experience
Blackstone, R. P. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.06.005 · Cited by 1
“Chronic hypoglycemia may have important health indications [3].”
BackgroundKo, S. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2025.2403 · Cited by 1
“In addition to causing uncom-fortable symptoms and fostering hypoglycemic fear, hypoglycemia is associated with several abnormalities that contribute to vascular risk, including arrhythmias, endothelial cell dysfunction, increased inflammation, and a prothrombotic environment [2].”
Haas, A. V., Koefoed, A. W., Celli, J., Bonyhay, I., White, J., Meyer, K. M., Easly-Merski, R. M., Heydarpour, M., Adler, G. K., & Freeman, R. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae919
Mechanisms of hypoglycaemia related sudden cardiac death in type 2 diabetes mellitus
Chow, E. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Self-citationQuah, J. X., Carlton, E. W., Rana, O., Byrne, C. D., Senior, R., Anstey, C., & Greaves, K. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.238
Mechanism of Hypoglycemia-Associated Cardiovascular Diseases
Kang, Y. M., & Lee, W. J. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.1.24
Hypoglykämien: Nur lästig oder auch gefährlich?
Kern, W. (2016) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-016-8385-8
Impacto cardiovascular de la hipoglicemia
Espitia, M. D. L. (2017) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.12.002 · Cited by 2
Ghazanfari, A., Vigmond, E. J., & Nygren, A. (2017) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-017-0315-0
Predicting severe hypoglycaemia — a step forward
Zaccardi, F., & Khunti, K. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.138 · Cited by 1
Старченко, Т. Г., Koval, S. M., Yushko, K. O., Shkapo, V. L., & Miloslavsky, D. К. (2018) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2018-3-1-145-42-46
Glycemic Metrics and Targets in Kidney Disease
Neumiller, J. J., & Hirsch, I. B. (2019) · Springer eBooks · doi:10.1007/978-3-319-97765-2_4
Persistent bradycardia after hypoglycaemia: a case report and a brief literature review
Gasperini, B., Lamanna, P., Serra, R., Montanari, R., Cherubini, A., & Espinosa, E. (2019) · Geriatric Care · doi:10.4081/gc.2019.7670
Hypoglycemia and Mortality in Critically Ill Patients with Type 2 Diabetes
Brož, J., & Malinovská, J. (2019) · Medical Principles and Practice · doi:10.1159/000503033
Interventionen am diabetischen Herzen
Zweiker, R., Zirlik, A., & Scherr, D. (2019) · Der Diabetologe · doi:10.1007/s11428-019-00554-1
Bala, C. G. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0036
“During a hyperinsulinemic hypoglycemic clamp in a study on healthy subjects, a slight amplification of the R wave, a decrease in the ST segment and a remarkable flattening of the T wave as well as a slight prolongation of the QT interval were demonstrated [7].”
BackgroundBahrmann, A., & Meyhöfer, S. (2020) · e Curriculum Innere Medizin · doi:10.1007/s40531-020-00038-8
Tang, K., Zhang, J., Yang, J., Liu, L., Li, L., Cui, J., & Wu, S. (2020) · Research Square · doi:10.21203/rs.3.rs-107433/v1
Hypoglycemia after Bariatric Surgery
Konda, S. (2021) · Journal of Obesity & Weight loss Therapy
Consoli, A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_21-1
Stoica, R. A., Frătița, D., Scafa‐Udriște, A., Fronea, O. F. G., Dorobanţu, M., Ionescu-Tirgoviste, C., & Guja, C. (2022) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2022.122012
Ko, S. (2022) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2022.4.e13 · Cited by 1
Antidiabetic agents and their hypothetical benefit on the risk of cardiac arrhythmias
Fauchier, L. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101406
Joshi, K., Das, M., Sarma, A., Arora, M. K., Singhal, M., & Kumar, B. (2023) · Current Hypertension Reviews · doi:10.2174/1573402119666230109142156
Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?
Davies, J. R. (2015) · EMJ Diabetes · doi:10.33590/emjdiabet/10310596
Type 2 diabetes management: from a glucose-centric approach to cardio-renal risk reduction
Jacob, S., Leschke, M., & Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00013-9 · Cited by 1
Kaiser, T., & Potthast, R. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-2144-6601
“Zur Frage, ob zusätzlich zur Erhebung und Auswertung von symptomatischen Hypoglykämien auch die Erhebung und Auswertung von Hypoglykämien mit einem Grenzwert von 54mg/dl ohne begleitende Symptome sinnvoll sein könnte, wurden folgende Punkte diskutiert: ▪ Für solche Ereignisse ist in epidemiologischen Studien ein Zusam…”
BackgroundValenzi, N. (2023) · Western Journal of Emergency Medicine · doi:10.5811/westjem.62602
Iqbal, A., Chow, E., Jones, T. W., & Heller, S. R. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch40
Self-citationДанилова, Л. И., Короленко, Г. Г., Lushchik, M. L., Романовский, А. А., Бурко, И. И., & Исачкина, О. Н. (2023) · Рецепт · doi:10.34883/pi.2023.26.5.014
THE EFFECT OF LINAGLIPTIN ON ARRHYTHMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Kaya, O. K., & Köker, G. (2024) · Kocatepe tıp dergisi. · doi:10.18229/kocatepetip.1195333
An intelligent remote diagnostic approach for diabetes using machine learning techniques
Kolekar, M. H., & Alekhya, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95686-4.00004-6
A review of hypoglycemia and dextrose treatment in patients with cardiac arrest
Goodwin, G., Hinton, M. R., Bengio, M., Patel, A., Gaeto, N., Tran, H. M., Kashan, S. B., & Zitek, T. (2025) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.24.305
“There is no strong evidence of a causal link between hypoglycemia and fatal arrhythmia in humans, but arrhythmias are thought to occur from sympathetic activation triggered by hypoglycemia followed by excessive vagal counteraction [6,7].”
徹, 谷., 光希, 正., 健太郎, 川., 喜久山紘太, 啓佑, 高., 泰之, 瓜., & 一晃, 安. (2025) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.12970
Electrocardiographic Changes of Sinoatrial Dysfunction in Hypoglycemia: A Case Report
López, L. A. R., Águila, Y. G., Esquerra, A. G., Cárdenas, M. D., & Leandro, D. C. (2025) · South Health and Policy · doi:10.56294/shp2024398
Dervişoğlu, M., Besen, D. B., & Günbaş, M. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.103450
Koufakis, T., Popovic, D. S., & Παπάνας, Ν. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70143
Predictors of Post‐Bariatric Surgery Hypoglycemia: A Multicenter Retrospective Cohort Study
Bahardoust, M., Ranjbarpazuki, A., Shamohammadi, M., Mousavi, A., Yarahmadi, D., Haghmoradi, M., Goodarzy, B., Garavand, A. A., & Tizmaghz, A. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70123 · Cited by 2
UK Resuscitation Advanced Life Support Guidelines: Should the Paradigm be Extended?
Jude, E. B., Saluja, S., Mannan, F., Heagerty, A. M., & Frier, B. M. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01813-9
“Chow and colleagues have shown that hypoglycaemia-induced cardiac arrhythmias are more common during the night when people with insulin-treated type 2 diabetes are asleep [10].”
InfluentialGao, L., Cheng, Z., Ma, G., Cai, X., Wang, X., Lu, Y., Li, Z., Li, W., Zhao, S., Li, X., et al. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70175
“Hypoglycemia is commonly associated with cardiac effects, including myocardial ischemia, arrhythmias, and cardiac failure 21,22 .”
Krysiak, D., Ćwiertnia, M., Wójcik, M., Babik, P., Suchanek, Ł., Jaśkiewicz, F., Trojak-Piętka, J., Szlagor, M. G., Waksmańska, W., Kawecki, M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238318
“It allows serious complications to be avoided, such as convulsions [35], heart rhythm disturbances [36], and even the death of the patient [37].”
Identifying Markers of Cardiac Arrythmias in Patients with Diabetes Mellitus Type 2
Papagiannopoulos, O. D., Georga, E. I., Idoyaga-Uribarrena, J., Arana-Arri, E., Pérez, L. L., Rujas, M., Temporale, C., Sánchez, G. C., de Battle, J., Pecchia, L., et al. (2025) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society · doi:10.1109/embc58623.2025.11251843
“Interactions between metabolic disorders and cardiovascular complications are highly intertwined, which is why patients with DM2 have a higher risk of arrhythmias [1, 2].”
Fujiki, S., Iijima, K., Nakagawa, Y., Takahashi, K., Okabe, M., Kusano, K., Owada, S., Kondo, Y., Tsujita, K., Shimizu, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26129759
Oh, P. C., Eom, Y. S., Moon, J., Jang, H.-J., Kim, T.-H., Suh, J., Kong, M. G., Park, S.-D., Kwon, S. W., Suh, S. Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13257473
Fujiki, S., Iijima, K., Nakagawa, Y., Takahashi, K., Okabe, M., Kusano, K., Owada, S., Kondo, Y., Tsujita, K., Shimizu, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26740853
Fujiki, S., Iijima, K., Nakagawa, Y., Takahashi, K., Okabe, M., Kusano, K., Owada, S., Kondo, Y., Tsujita, K., Shimizu, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26129848
Fujiki, S., Iijima, K., Nakagawa, Y., Takahashi, K., Okabe, M., Kusano, K., Owada, S., Kondo, Y., Tsujita, K., Shimizu, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26740856
Zhou, Y. P., Rautio, E., Näsman, P., Guðbjörnsdóttir, S., Gadler, F., Rydén, L., Wodaje, T., & Mellbin, L. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03044-5 · Cited by 1
“Ventricular tachyarrhythmias were less frequently recorded as an ECG-indication for type 2 diabetes patients, despite their reported higher arrhyth-mic risk [4, 5].”
Kézdi, Á., Horváth, V. J., Vass, V., Svébis, M. M., Kocsis, G., Ferencz, V., Jávorfí, T., Domján, B. A., & Tabák, Á. G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1690371
Inoue, A., Takahashi, N., Dote, K., Maruta, K., Hori, Y., Tsukaguchi, H., Adachi, K., 吉岡さおり, Tomoi, A., Kitamura, A., et al. (2026) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.59.24
贾, 宏. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.163804
Kobayashi, S., Nagao, M., Fukuda, I., Oikawa, S., & Iwabu, M. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261448416
Lv, J. G., Ye, Z., Tan, H., & Yuke, L. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-026-01677-0
Sanke, T., Matsuoka, Y., Yamada, S., & Kadoya, Y. (2026) · Diabetology · doi:10.3390/diabetology7070123
“Among these, nocturnal hypoglycemia can induce severe arrhythmias and may sometimes be life-threatening [6].”
Craig, C. M., Tan, M. J., Shamloo, T., Perelman, D., & McLaughlin, T. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156773
Rationale and design of the Atherosclerosis Risk in Communities Generation 2 study
Wang, D., Daya, N. R., Rooney, M. R., Valint, A., Minotti, M., Fang, M., Luo, S., Wagenknecht, L. E., Windham, B. G., Lutsey, P. L., et al. (2026) · American Journal of Epidemiology · doi:10.1093/aje/kwag237
Cardiotropic effects of hypoglycemia in patients with diabetes mellitus
Салухов, В. В., Феофанова, С. Г., Владимировна, П. Е., & Zaslavskaya, E. L. (2026) · The future of medicine · doi:10.67666/3033-9057-2026-1-2-89-101
“Таким образом, брадикардия во время ночной гипогликемии может быть объяснена торможением симпатической активности ввиду гиперактивации блуждающего нерва [24], что было также воспроиз - ведено и у пациентов с СД 2-го типа во время гипе - ринсулинемического гипогликемического клэмпа [17].”
Metadata
- Authors
- Chow, E., Bernjak, A., Williams, S., Fawdry, R. A., Hibbert, S., Freeman, J., Sheridan, P. J., & Heller, S. R.
- Affiliations
- University of Sheffield (GB)
- Corresponding author
- Heller, Simon R.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-04-12
- Volume
- 63
- Issue
- 5
- Pages
- 1738-1747
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2042767418
- Cited by
- 403
- References
- 46
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 19 · 2023: 25 · 2022: 30 · 2021: 40 · 2020: 33 · 2019: 25 · 2018: 51 · 2017: 40 · 2016: 41 · 2015: 44 · 2014: 8
- FWCI
- 35.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0611-10248, ACF-2008-04-002, BRF-2011-004)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypoglycemia, cardiac arrhythmias, type 2 diabetes, cardiovascular risk, nocturnal hypoglycemia, bradycardia, cardiac repolarization, QT interval, heart rate variability, insulin-treated patients, cardiovascular mortality, tight glycemic control, Holter monitoring
- MeSH terms
- Aged, Arrhythmias, Cardiac, Autonomic Nervous System, Blood Glucose, Diabetes Mellitus, Type 2, Female, Heart, Heart Rate, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Middle Aged, Risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.